Evidence map›Paper›PMID 38139888›Full record

ArticlePolymers2023

Poly(ethylene Glycol) Methyl Ether Methacrylate-Based Injectable Hydrogels: Swelling, Rheological, and In Vitro Biocompatibility Properties with ATDC5 Chondrogenic Lineage.

Yousof Farrag, Djedjiga Ait Eldjoudi, Mariam Farrag, María González-Rodríguez, Clara Ruiz-Fernández, Alfonso Cordero, María Varela-García, Carlos Torrijos Pulpón, Rebeca Bouza, Francisca Lago and 3 more

Abstract read
In one paragraph

Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yousof FarragServizo Galego de Saude (SERGAS) and Instituto de Investigación Sanitaria de Santiago (IDIS), Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases (NEIRID Group), Santiago University Clinical Hospital, Building C, Travesía da Choupana S/N, 15706 Santiago de Compostela, Spain.ORCID 0000-0003-1715-8157
Djedjiga Ait EldjoudiServizo Galego de Saude (SERGAS) and Instituto de Investigación Sanitaria de Santiago (IDIS), Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases (NEIRID Group), Santiago University Clinical Hospital, Building C, Travesía da Choupana S/N, 15706 Santiago de Compostela, Spain.
Mariam FarragServizo Galego de Saude (SERGAS) and Instituto de Investigación Sanitaria de Santiago (IDIS), Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases (NEIRID Group), Santiago University Clinical Hospital, Building C, Travesía da Choupana S/N, 15706 Santiago de Compostela, Spain.
María González-RodríguezServizo Galego de Saude (SERGAS) and Instituto de Investigación Sanitaria de Santiago (IDIS), Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases (NEIRID Group), Santiago University Clinical Hospital, Building C, Travesía da Choupana S/N, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-8878-2219
Clara Ruiz-FernándezServizo Galego de Saude (SERGAS) and Instituto de Investigación Sanitaria de Santiago (IDIS), Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases (NEIRID Group), Santiago University Clinical Hospital, Building C, Travesía da Choupana S/N, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-7959-9826
Alfonso CorderoServizo Galego de Saude (SERGAS) and Instituto de Investigación Sanitaria de Santiago (IDIS), Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases (NEIRID Group), Santiago University Clinical Hospital, Building C, Travesía da Choupana S/N, 15706 Santiago de Compostela, Spain.ORCID 0000-0002-0827-8977
María Varela-GarcíaServizo Galego de Saude (SERGAS) and Instituto de Investigación Sanitaria de Santiago (IDIS), Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases (NEIRID Group), Santiago University Clinical Hospital, Building C, Travesía da Choupana S/N, 15706 Santiago de Compostela, Spain.ORCID 0009-0002-8958-4163
Carlos Torrijos PulpónServizo Galego de Saude (SERGAS) and Instituto de Investigación Sanitaria de Santiago (IDIS), Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases (NEIRID Group), Santiago University Clinical Hospital, Building C, Travesía da Choupana S/N, 15706 Santiago de Compostela, Spain.
Rebeca BouzaGrupo de Polímeros, Departamento de Física y Ciencias de la Tierra, Escuela Universitaria Politécnica, Universidade da Coruña, Serantes, Avda. 19 de Febrero s/n, 15471 Ferrol, Spain.
Francisca LagoServizo Galego de Saude (SERGAS) and Instituto de Investigación Sanitaria de Santiago (IDIS), Molecular and Cellular Cardiology Lab, Research Laboratory 7, Santiago University Clinical Hospital, C, Travesía da Choupana S/N, 15706 Santiago de Compostela, Spain.
Jesus PinoServizo Galego de Saude (SERGAS) and Instituto de Investigación Sanitaria de Santiago (IDIS), Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases (NEIRID Group), Santiago University Clinical Hospital, Building C, Travesía da Choupana S/N, 15706 Santiago de Compostela, Spain.
Carmen Alvarez-LorenzoI+D Farma Group (GI-1645), Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Instituto de Materiales (iMATUS), Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.ORCID 0000-0002-8546-7085
Oreste GualilloServizo Galego de Saude (SERGAS) and Instituto de Investigación Sanitaria de Santiago (IDIS), Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases (NEIRID Group), Santiago University Clinical Hospital, Building C, Travesía da Choupana S/N, 15706 Santiago de Compostela, Spain.ORCID 0000-0002-7154-1328

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we present the synthesis of a series of chemical homopolymeric and copolymeric injectable hydrogels based on polyethylene glycol methyl ether methacrylate (PEGMEM) alone or with 2-dimethylamino ethyl methacrylate (DMAEM). The objective of this study was to investigate how the modification of hydrogel components influences the swelling, rheological attributes, and in vitro biocompatibility of the hydrogels. The hydrogels' networks were formed via free radical polymerization, as assured by

Indexed as

biocompatibilitybiopolymersDMAEMinjectable hydrogelsPEGMEM

Identifiers

PMID38139888
PMCPMC10747511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.